AstraZeneca

AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company dedicated to the discovery, development, and commercialization of prescription medicines.

With a global presence, AstraZeneca focuses on key therapeutic areas, including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

Company History

The company was established in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group.

This strategic consolidation combined Astra's expertise in gastrointestinal and cardiovascular treatments with Zeneca's strengths in oncology and respiratory medicines.

The merger created a robust portfolio that addresses a wide range of medical needs.

Research and Development Centers

AstraZeneca's research and development (R&D) efforts are concentrated in three strategic centers:

• Cambridge, UK
• Gothenburg, Sweden
• Gaithersburg, Maryland, USA

These hubs drive innovation across the company's diverse therapeutic areas, ensuring a continuous pipeline of new treatments.

U.S. Locations

In the United States, AstraZeneca operates multiple sites, including major locations in Gaithersburg, Maryland, and Wilmington, Delaware.

The majority of U.S. employees collaborate on global projects at these locations.

Additional U.S. sites include:

• Frederick, MD
• Waltham, MA
• Coppell, TX
• Newark, DE
• New York, NY
• Durham, NC
• Redwood City, CA
• San Francisco, CA
• Mount Vernon, IN
• Shepherdsville, KY
• Philadelphia, PA

Innovation and Acquisitions

AstraZeneca's commitment to innovation is reflected in significant investments in R&D and strategic acquisitions.

In March 2023, the company finalized its acquisition of CinCor Pharma, a U.S.-based clinical-stage biopharmaceutical company focused on developing novel treatments for resistant and uncontrolled hypertension, as well as chronic kidney disease.

In November 2023, AstraZeneca launched Evinova, a global health tech business aimed at providing digital health solutions to optimize clinical trial design and delivery.

Sustainability Initiatives

The company is dedicated to sustainability through its Ambition Zero Carbon strategy, which aims to achieve zero carbon emissions by 2045 and halve its carbon footprint by 2030.

AstraZeneca also focuses on creating sustainable offices in Madrid and Barcelona to provide a healthy and efficient work environment.

Summary

Through its unwavering focus on science-led innovation, strategic global presence, and dedication to sustainability, AstraZeneca continues to make significant contributions to global health.

The company is committed to improving the lives of patients worldwide.

Additional U.S. Locations

• Cleveland, OH
• Fargo, ND